February 2023 CORPORATE OVERVIEW Innovative Therapeutics to Treat Immune-Mediated Diseases Nasdaq: ALDX © Aldeyra Therapeutics, Inc. 2023 Disclaimers and Forward-Looking Statements ...

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q3 2022 Earnings Conference Call November 10, 2022 8:00 AM ET Company Participants Bruce Greenberg - Interim Chief Financial Officer Todd Brady - President and Chief Executive Officer Conference Call Participants Marc Goodman - SVB Securities Justin Kim - Oppenheimer Yale Jen - Laidlaw & Co. Catherine Novack - Jones Research Operator Ladies and gentlemen, thank you for standing by and welcome to the Aldeyra Therapeutics Third Quarter 2022 Financial Results Conference ...

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q2 2022 Earnings Conference Call August 5, 2022 8:00 AM ET Company Participants Bruce Greenberg - Interim Chief Financial Officer Todd Brady - President & Chief Executive Officer Conference Call Participants Catherine Novack - Jones Research Yigal Nochomovitz - Citigroup Kelly Shi - Jefferies Tom Shrader - BTIG Justin Kim - Oppenheimer & Co. Yale Jen - Laidlaw & Company Operator Ladies and gentlemen, thank you for standing by and welcome to the Aldeyra Therapeutics S ...

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants Joshua Reed - Chief Financial Officer Dr. Todd Brady - Chief Executive Officer Bruce Greenberg - Incoming Interim CFO Conference Call Participants Justin Kim - Oppenheimer Marc Goodman - SVB Leerink Yigal Nochomovitz - Citi Kelly Shi - Jefferies Sung Hong - BTIG Matthew Cross - Alliance Global Partners Catherine Novack - Jones Trading Elaine Kim - Berenberg Yale Jen - Laidlaw Capital Operator ...

Aldeyra Therapeutics (NASDAQ:ALDX) Q4 2021 Earnings Conference Call March 17, 2021 8:00 AM ET Company Participants Joshua Reed – Chief Financial Officer Todd Brady – President and Chief Executive Officer Conference Call Participants Yigal Nochomovitz – Citigroup Marc Goodman – SVB Leerink Sung Ji Nam – BTIG Matthew Cross – Alliance Global Partners I-Eh Jen – Laidlaw & Company Operator Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics’ Full Year 2021 Financial Results C ...